Cohance Lifesciences Limited (COHANCE) announced an additional USD 13 million investment in NJ Bio and USD 5 million in Aruka Bio to strengthen its Antibody-.
Cohance Lifesciences Limited (NSE: COHANCE) stock price moves up 5% intraday to ₹470.8, breaking out from its 6M resistance trendline.
Cohance Lifesciences Limited (COHANCE) reports Q1FY27 financial results, with revenue down 23.1% YoY, expects rebound in H2.
Cohance Lifesciences Limited (NSE: COHANCE) is down 5% intraday at ₹418.9, showing pressure after breakout. Key momentum test at 50-DMA (₹443.8).
Cohance Lifesciences Limited (NSE: COHANCE) stock breaks out, gaining 12% intraday. The stock has cleared its 6M resistance trendline.
Cohance Lifesciences Limited (NSE: COHANCE) stock price rises 5% intraday to ₹428.65, showing a climb in the Healthcare sector.
Cohance Lifesciences Limited (COHANCE) reports FY26 Q4 results, showcasing strategic growth alignment and a transition year outlook for FY27.